Recently Published Articles on Vitiligo

Below you will find a list of recently published articles on vitiligo, subdivided into Review Articles, Clinical Articles, and Basic Science Articles. Each article is linked to its listing in PubMed. Please note that, due to copyright restrictions, the National Vitiligo Foundation can not provide a direct link to the full text or PDF version of the article.

To view articles from January through June 2009, please click here.

Review Articles

DECEMBER 2009

Nordlund JJ. Nonmelanoma skin cancer in vitiligo patients. J Am Acad Dermatol. 2009 Dec;61(6):1080-1.

Lotti T, Berti S, Moretti S. Vitiligo therapy. Expert Opin Pharmacother. 2009 Dec;10(17):2779-85.

Jalel A, Soumaya GS, Hamdaoui MH. Dermatology life quality index scores in vitiligo: reliability and validity of the tunisian version. Indian J Dermatol. 2009;54(4):330-3.

Falabella R. Vitiligo and the melanocyte reservoir. Indian J Dermatol. 2009;54(4):313-8.

Lahiri K. Evolution and evaluation of autologous mini punch grafting in vitiligo. Indian J Dermatol. 2009;54(2):159-67.

Khunger N, Kathuria SD, Ramesh V. Tissue grafts in vitiligo surgery - past, present, and future. Indian J Dermatol. 2009;54(2):150-8.

Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clin Exp Dermatol. 2009 Dec 8.


NOVEMBER 2009

Kakourou T. Vitiligo in children. World J Pediatr. 2009 Nov;5(4):265-8.

Osman AM, Elkordufani Y, Abdullah MA. The psychological impact of vitiligo in adult Sudanese patients. Afr J Psychiatry (Johannesbg). 2009 Nov;12(4):284-6.


OCTOBER 2009

Gawkrodger DJ. Vitiligo: what general physicians need to know. Clin Med. 2009 Oct;9(5):408-9.

Gawkrodger DJ. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. Br J Dermatol. 2009 Oct;161(4):721-2.

Anbar TS, Abdel-Raouf H, Awad SS, Ragaie NH, Abdel-Rahman AT. Presence of eosinophils in the inflammatory infiltrate of nonsegmental vitiligo:retrospective study. Clin Exp Dermatol. 2009 Oct;34(7):e496-7.


SEPTEMBER 2009

Alzolibani A. Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta Dermatovenerol Alp Panonica Adriat. 2009 Sep;18(3):119-25.

Michelsen D. The Double Strike Hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma. Med Hypotheses. 2009 Sep 10.


JULY 2009

Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, Wietze van der Veen JP. The burden of vitiligo: Patient characteristics associated with quality of life. J Am Acad Dermatol. 2009 Jul 2.

Boissy RE, Spritz RA. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol. 2009 Jul; 18(7): 583-5.

Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, Taieb A. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009 Jul; 161(1): 128-33.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009 Jul; 161(1): 134-9.


Return to top of page

Clinical Articles

DECEMBER 2009

Lee DY, Kim PS, Lee JH. Mixed vitiligo treated by suction blister epidermal grafting: Long-term follow up. J Dermatol. 2009 Dec;36(12):672-3.

Jalel A, Soumaya GS, Hamdaoui MH. Vitiligo treatment with vitamins, minerals and polyphenol supplementation. Indian J Dermatol. 2009;54(4):357-60.

Majid I, Masood Q, Hassan I, Khan D, Chisti M. Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination. Indian J Dermatol. 2009;54(2):124-7.

da Silva VB, Kawano DF, Carvalho I, da Conceição EC, de Freitas O, da Silva CH. Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo. J Pharm Pharm Sci. 2009;12(3):378-87.

Klahan S, Asawanonda P. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study. Clin Exp Dermatol. 2009 Dec;34(8):e1029-30.

Lee DY, Choi SC, Park JH, Lee JH, Yang JM, Lee ES. Repigmentation after epidermal grafting of vitiligo epidermis into normal skin in segmental vitiligo. Clin Exp Dermatol. 2009 Dec;34(8):e1019.

Jalel A, Hamdaoui MH. Study of total antioxidant status and glutathione peroxidase activity in tunisian vitiligo patients. Indian J Dermatol. 2009;54(1):13-6.

Iftikhar N, Rahman A, Janjua SA. Vitiligo appearing in striae distensae as a koebner phenomenon. J Coll Physicians Surg Pak. 2009 Dec;19(12):796-7.

Goh BK, Chua XM, Chong KL, DE Mil M, VAN Geel NA. Simplified Cellular Grafting for Treatment of Vitiligo and Piebaldism: The "6-Well Plate" Technique. Dermatol Surg. 2009 Dec 21.

Cervelli V, De Angelis B, Balzani A, Colicchia G, Spallone D, Grimaldi M. Treatment of Stable Vitiligo by ReCell System. Acta Dermatovenerol Croat. 2009;17(4):273-8.

Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat. 2009;20(6):328-35.


NOVEMBER 2009

Onsun N, Büyükbabani N, Ummetoğlu O, Cebeci F. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo. J Dermatol. 2009 Nov;36(11):612-5.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Is segmental vitiligo always associated with leukotrichia? Examination with a digital portable microscope. Int J Dermatol. 2009 Nov;48(11):1262.


OCTOBER 2009

Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of Korean adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2009 Oct 6.

Mulekar SV, Al Eisa A, Delvi MB, Al Issa A, Al Saeed AH. Childhood Vitiligo: A Long-term Study of Localized Vitiligo Treated by Noncultured Cellular Grafting. Pediatr Dermatol. 2009 Oct 4.


SEPTEMBER 2009

Lee DY, Choi SC, Lee JH. Comparison of suction blister and carbon dioxide laser for recipient site preparation in epidermal grafting of segmental vitiligo. Clin Exp Dermatol. 2009 Sep 15.

Kossakowska MM, Cieścińska C, Jaszewska J, Placek WJ. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol. 2009 Sep 10.


AUGUST 2009

Stinco G, Piccirillo F, Forcione M, Valent F, Patrone P. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. Eur J Dermatol. 2009 Aug 4.

Gowda S, Tillman DK, Fitzpatrick JE, Gaspari AA, Goldenberg G. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. J Cutan Pathol. 2009 Aug; 36(8): 878-81.

Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. J Eur Acad Dermatol Venereol. 2009 Aug; 23(8): 951-3.


JULY 2009

Lee DY, Choi SC, Lee JH. Generalized vitiligo treated by combination therapy of epidermal graft and systemic corticosteroid. Clin Exp Dermatol. 2009 Jul 29.

Saraceno R, Nisticò SP, Capriotti E, Chimenti S. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Dermatol Ther. 2009 Jul-Aug; 22(4) :391-4.

Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol. 2009 Jul; 49(7): 852-5.

Yuksel EP, Aydin F, Senturk N, Canturk T, Turanli AY. Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients. Eur J Dermatol. 2009 Jul-Aug; 19(4): 341-4.

Fongers A, Wolkerstorfer A, Nieuweboer-Krobotova L, Krawczyk P, Tóth GG, van der Veen JP. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity. Br J Dermatol. 2009 Jun 22.

Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009 May-Jun; 26(3): 354-6.

Farajzadeh S, Daraei Z, Esfandiarpour I, Hosseini SH. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study. Pediatr Dermatol. 2009 May-Jun; 26(3): 286-91.


Return to top of page

Basic Science Articles

DECEMBER 2009

Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8. J Invest Dermatol. 2009 Nov 5.


NOVEMBER 2009

Misri R, Khopkar U, Shankarkumar U, Ghosh K. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo. Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):583-7.

Jeong KH, Shin MK, Uhm YK, Kim HJ, Chung JH, Lee MH. Association of TXNDC5 Gene Polymorphisms and Non-segmental Vitiligo Susceptibility in the Korean Population. Br J Dermatol. 2009 Nov 10.

Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8. J Invest Dermatol. 2009 Nov 5.


OCTOBER 2009

Serarslan G, Yonden Z, Sogut S, Savas N, Celik E, Arpaci A. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. Clin Exp Dermatol. 2009 Oct 23.

Zamani M, Tabatabaiefar MA, Mosayyebi S, Mashaghi A, Mansouri P. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clin Exp Dermatol. 2009 Oct 19.

Soylu S, Gül U, Gönül M, Kılıç A, Cakmak SK, Demiriz M. An Uncommon Presentation of the Co-Existence of Morphea and Vitiligo in a Patient with Chronic Hepatitis B Virus Infection: Is There a Possible Association with Autoimmunity? Am J Clin Dermatol. 2009 Oct 1;10(5):336-338.


SEPTEMBER 2009

Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol. 2009 Sep 17.

Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA. Fine-Mapping of Vitiligo Susceptibility Loci on Chromosomes 7 and 9 and Interactions with NLRP1 (NALP1). J Invest Dermatol. 2009.


AUGUST 2009

Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC. Monobenzyl Ether of Hydroquinone and 4-Tertiary Butyl Phenol Activate Markedly Different Physiological Responses in Melanocytes: Relevance to Skin Depigmentation. J Invest Dermatol. 2009 Aug 6.

Anbar TS, Abdel-Raouf H, Awad SS, Ragaie MH, Abdel-Rahman AT. The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol. 2009 Aug; 23(8): 934-9.


JULY 2009

Kumar R, Parsad D, Kaul D, Kanwar A. Liver X receptor expression in human melanocytes, does it have a role in the pathogenesis of vitiligo? Exp Dermatol. 2009 Jul 23.

Salem MM, Shalbaf M, Gibbons NC, Chavan B, Thornton JM, Schallreuter KU. Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J. 2009 Jul 29. [Epub ahead of print]

Manini P, Napolitano A, Westerhof W, Riley PA, d'Ischia M. A Reactive ortho-Quinone Generated by Tyrosinase-Catalyzed Oxidation of the Skin Depigmenting Agent Monobenzone: Self-Coupling and Thiol-Conjugation Reactions and Possible Implications for Melanocyte Toxicity. Chem Res Toxicol. 2009 Jul 17.

Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library. J Invest Dermatol. 2009 Jul 9.

Liu L, Li C, Gao J, Li K, Gao L, Gao T. Genetic Polymorphisms of Glutathione S-Transferase and Risk of Vitiligo in the Chinese Population. J Invest Dermatol. 2009 Jul 2.

Jain D, Misra R, Kumar A, Jaiswal G. Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years. Indian J Physiol Pharmacol. 2008 Jul-Sep; 52(3): 297-301.

Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol. 2009 Jul; 24(7): 849-57.

Balci DD, Yonden Z, Yenin JZ, Okumus N. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. Eur J Dermatol. 2009 Jul-Aug; 19(4): 382-3.

Dwivedi M, Gupta K, Gulla KC, Laddha NC, Hajela K, Begum R. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo. Br J Dermatol. 2009 Jul; 161(1): 63-9.

Diao JS, Zhang X, Xia WS, Zheng Y, Ren J, Wang YM, Gong Z, Xia W, Guo SZ. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Med Hypotheses. 2009 Jul; 73(1): 70-2.


Return to top of page